Life Bioscience Enters 'Competitive' Slide Market with 3D Glass Microarrays
August 11, 2009
Life Bioscience Enters 'Competitive' Slide Market with 3D Glass Microarrays
The firm's new Oracle 3D glass nanowell microarray substrates are targeted towards customers that use protein arrays for research, in drug discovery, and, potentially, in the clinic.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Schott Partners with Applied Microarrays to Reach More Array Customers in North America
January 29, 2013 / BioArray News - BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers
June 17, 2011 / ProteoMonitor - Thermo Fisher Adds to Specialty-Dx Business with $3.5B Phadia Buy
May 20, 2011 / ProteoMonitor - Advances Position Surface-Enhanced Raman as Potential ELISA Alternative
April 1, 2011 / ProteoMonitor - Recent Patents of Interest in Proteomics
July 16, 2010 / ProteoMonitor